Charles Schwab
ALNA

Charles Schwab’s Allena Pharmaceuticals ALNA Stock Holding History

Charles Schwab’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-28,139
Closed -$198K – 3287
2019
Q1 		$198K Buy
28,139
+6,539
+30% +$47.4K ﹤0.01% 3024
2018
Q4 		$118K Hold
21,600
– – ﹤0.01% 3082
2018
Q3 		$232K Hold
21,600
– – ﹤0.01% 3052
2018
Q2 		$282K Buy
+21,600
New +$311K ﹤0.01% 2997

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Charles Schwab's ALNA Position: Q2 2019 in Review

Charles Schwab sold out of Allena Pharmaceuticals (ALNA) in Q2 2019, closing a stake of 28,139 shares — an estimated $198K sold.

Charles Schwab first reported a position in ALNA in Q2 2018 and held it in 4 quarters. The position peaked at $282K in Q2 2018. 46 funds tracked by Wall St. Rank hold ALNA as of Q2 2019.

  • Charles Schwab reported no remaining Allena Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Charles Schwab sold 28,139 Allena Pharmaceuticals shares in Q2 2019, an estimated $198K.
  • Charles Schwab first reported a position in Allena Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Charles Schwab's Allena Pharmaceuticals position peaked at $282K in Q2 2018.
  • 46 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2019.

Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.